0001104659-24-094012.txt : 20240828
0001104659-24-094012.hdr.sgml : 20240828
20240828163100
ACCESSION NUMBER: 0001104659-24-094012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240826
FILED AS OF DATE: 20240828
DATE AS OF CHANGE: 20240828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TETRAULT LYNN A.
CENTRAL INDEX KEY: 0001645512
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 241255941
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm2422915-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-08-26
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001645512
TETRAULT LYNN A.
222 BERKELEY STREET,
12TH FLOOR
BOSTON
MA
02116
1
0
0
0
1
Common Stock
2024-08-26
4
M
0
4300
18.99
A
7300
D
Common Stock
2024-08-26
4
S
0
4300
50.0067
D
3000
D
Stock Option (right to buy)
18.99
2024-08-26
4
M
0
4300
0.00
D
2031-06-08
Common Stock
4300
10700
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024.
The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.03. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.
/s/ Hunter Smith, attorney-in-fact for Lynn A. Tetrault
2024-08-28